0001754526-23-000002.txt : 20231023 0001754526-23-000002.hdr.sgml : 20231023 20231023162352 ACCESSION NUMBER: 0001754526-23-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231019 FILED AS OF DATE: 20231023 DATE AS OF CHANGE: 20231023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harsaul Foundation CENTRAL INDEX KEY: 0001754526 STATE OF INCORPORATION: R1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38709 FILM NUMBER: 231340215 BUSINESS ADDRESS: STREET 1: EDIFICIO AFRA STREET 2: AVENIDA SAMUEL LEWIS Y CALLE 54 CITY: PANAMA STATE: R1 ZIP: 0 BUSINESS PHONE: 5072639355 MAIL ADDRESS: STREET 1: EDIFICIO AFRA STREET 2: AVENIDA SAMUEL LEWIS Y CALLE 54 CITY: PANAMA STATE: R1 ZIP: 0 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RVL Pharmaceuticals plc CENTRAL INDEX KEY: 0001739426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 9088091300 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Osmotica Pharmaceuticals plc DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: Osmotica Pharmaceuticals Ltd DATE OF NAME CHANGE: 20180502 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-10-19 1 0001739426 RVL Pharmaceuticals plc RVLP 0001754526 Harsaul Foundation EDIFICIO AFRA AVENIDA SAMUEL LEWIS Y CALLE 54 PANAMA R1 0 PANAMA 0 0 1 0 0 Ordinary Shares 2023-10-19 4 S 0 9363760 0.0461 D 9700000 I By Self as indirect owner of Altchem Limited Ordinary Shares 2023-10-20 4 S 0 4758899 0.0312 D 4941101 I By Self as indirect owner of Altchem Limited The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0400 to $0.0580, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents shares of the Issuer held by Altchem Limited. Harsaul Foundation is the indirect owner of Altchem Limited. As a result, Harsaul Foundation may be deemed to share voting and investment power with respect to the shares held by Altchem Limited. The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0300 to $0.0373, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/CAMILO A. MENDEZ CHONG, Harsaul Foundation, by Dirserv Inc., Foundation Council Member, By: Camilo A. Mendez Chong 2023-10-23